TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharma-Hus AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,302
|
20,288
|
19,111 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
935
|
647
|
186 |
| EBITDA |
989
|
739
|
273 |
| Total assets |
4,288
|
0
|
6,572 |
| Current assets |
4,188
|
0
|
6,159 |
| Current liabilities |
2,378
|
0
|
5,052 |
| Equity capital |
1,676
|
0
|
1,260 |
| - share capital |
65
|
0
|
67 |
| Employees (average) |
4
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency | 39.1% | 19.2% | |
| Turnover per employee |
4,326
|
4,058
|
3,822 |
| Profit as a percentage of turnover |
5.4%
|
3.2%
|
1.0% |
| Return on assets (ROA) | 21.8% | 2.8% | |
| Current ratio | 176.1% | 121.9% | |
| Return on equity (ROE) | 55.8% | 14.8% | |
| Change turnover |
-2,315
|
1,079
|
799 |
| Change turnover % |
-12%
|
6%
|
4% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-20%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.